Aratana Therapeutics Balance Sheet - Annual (NASDAQ:PETX)

Add to My Stocks
$5.84 $0.39 (7.16%) PETX stock closing price Sep 19, 2018 (Closing)

A thorough fundamental analysis involves using data from Aratana Therapeutics balance sheet, apart from other financial statements, to value the business. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Aratana Therapeutics stock analysis. Annual results are typically accompanied with the company releasing financial statements. The Aratana Therapeutics balance sheet for 2017 shows total assets of $135.19M. The company has a asset turnover ratio of 0.15. Also see: Aratana Therapeutics revenue and Aratana Therapeutics operating cash flow for the same year.

View latest 10 year balance sheet data to check Aratana Therapeutics financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Marketable Securities--59.44M88.24M4.67M6.38M6.38M
Raw Materials1.13M1.44M-----
Work In Progress12.32M8.15M-----
Finished Goods-1.53M-----
Notes Receivable-------
Other Current Assets1.64M2.02M1.45M1.05M1.65M--
Total Current Assets
Property Plant & Equipment2.35M2.86M2.98M----
Accumulated Depreciation1.18M------
Net Property Plant & Equipment
Investment & Advances---2.45M---
Other Non-Current Assets-------
Deferred Charges-------
Deposits & Other Assets---1.2M---
Total Assets
Notes Payable----3M--
Accounts Payable7.45M7.43M1.4M1.53M2.3M--
Current Portion Long-Term Debt17.33M14.41M--5.62M--
Current Portion Capital Leases-------
Accrued Expenses3.71M5.82M4.24M3.22M2.49M1.36M-
Income Taxes Payable-------
Other Current Liabilities7M7.01M-4.29M3.47M1.36M-
Total Current Liabilities
Deferred Taxes/Income---1.61M1.66M--
Convertible Debt-------
Long-Term Debt19.49M25.77M39.71M14.96M9.31M--
Non-Current Capital Leases-------
Other Long-Term Liabilities----1.61M--
Total Liabilities
Minority Interest-------
Preferred Stock-----39.19M22.15M
Common Stock Net-------
Capital Surplus321.59M286.9M263.94M254.99M112.51M--
Retained Earnings-233.31M-185.59M-152.01M-67.96M-26.49M-22.21M-10.57M
Treasury Stock1.1M1.08M1.08M1.08M---
Other Liabilities-7.08M-9.86M-9.32M-4.15M---
Shareholders Equity80.13M90.4M101.55M181.83M86.04M17.64M11.88M
Total Liabilities & Shareholders Equity135.19M151.4M147.06M207.9M115.53M21.22M12.57M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the Aratana Therapeutics stock price by looking at Aratana Therapeutics historical stock prices. One can compare PE with industry average by looking at the Aratana Therapeutics PE ratio chart. The common balance sheet items are:

  • Assets: Anything that the Aratana Therapeutics company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Aratana Therapeutics had total assets of $135.19M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. PETX stock had total liabilities of $55.05M for the year 2017.

Aratana Therapeutics Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio